ZBNA
NVO

Zions Bancorporation, National Association’s Novo Nordisk NVO Stock Holding History

Zions Bancorporation, National Association’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30.9K Sell
644
-735
-53% -$31.6K ﹤0.01% 664
2026
Q1 		$50.7K Sell
1,379
-19,937
-94% -$945K ﹤0.01% 530
2025
Q4 		$1.08M Sell
21,316
-14,743
-41% -$754K 0.05% 234
2025
Q3 		$2M Sell
36,059
-30,370
-46% -$1.78M 0.1% 142
2025
Q2 		$4.58M Buy
66,429
+12,033
+22% +$818K 0.25% 83
2025
Q1 		$3.78M Buy
+54,396
New +$4.49M 0.24% 91

Other funds holding NVO

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
SRIM
Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return
MG
Markel Group Glen Allen, Virginia $13.1B AUM 15.62% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Zions Bancorporation, National Association's NVO Position: Q2 2026 in Review

Zions Bancorporation, National Association reduced its Novo Nordisk (NVO) stake by 53% in Q2 2026, selling an estimated $31.6K and leaving 644 shares worth $30.9K. The position accounts for ﹤0.01% of the portfolio, ranked #664.

Zions Bancorporation, National Association first reported a position in NVO in Q1 2025 and has held it in 6 quarters since. The position peaked at $4.58M in Q2 2025. 654 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Zions Bancorporation, National Association held 644 shares of Novo Nordisk worth $30.9K as of Q2 2026.
  • Zions Bancorporation, National Association sold 735 Novo Nordisk shares in Q2 2026, an estimated $31.6K.
  • Novo Nordisk made up ﹤0.01% of Zions Bancorporation, National Association's portfolio in Q2 2026, its #664 holding.
  • Zions Bancorporation, National Association first reported a position in Novo Nordisk in Q1 2025 and has held it in 6 quarters since.
  • Zions Bancorporation, National Association's Novo Nordisk position peaked at $4.58M in Q2 2025.
  • 654 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Zions Bancorporation, National Association's 13F filing for Q2 2026, filed 31 Jul 2026.